by admin | Dec 22, 2020 | News
Exogenus Therapeutics is currently developing an innovative treatment for acute lung inflammation, based on naturally-occurring vesicles that facilitate cellular communication. After securing funding from Portugal 2020 and the European Union for its ExoLUNG project,...
by admin | Nov 23, 2020 | News
Joana Correia, CEO and CSO of Exogenus Therapeutics is an invited speaker at the 2nd Exosome Based Therapeutic Development Summit, taking place during November 11-12 (online). Joana will be joined by other world leaders in exosome development to discuss the pains and...
by admin | May 13, 2019 | News
Joana Correia, founder, Executive Director and Chief Scientific Officer of Exogenus Therapeutics will be presenting at the 14th World Advanced Therapies and Regenerative Medicine Congress taking place 15th to 17th of May in London. Joana will be presenting Exogenus’s...
by admin | Apr 15, 2019 | News
Exogenus Therapeutics is the winner of the 2nd edition of Prémio Empreendedor XXI, Portugal – North and Central Regions. This prize is organized by BPI and DayOne, a division of CaixaBank specialized in technological companies, in partnership with Agência...
by admin | Nov 5, 2018 | News
Exogenus is amongst the 500 deeptech startups running for the Hello Tomorrow Global Challenge. The Hello Tomorrow Global Challenge is a worldwide renowned science & technology startup competition designed specifically to address the needs of...
